[O1] Oral Session 1　Gastrointestinal Cancer 1（Upper GI Tract）
【E】

[O1-5] Bemarituzumab as a 1L Therapy for Advanced GC/GEJ - A Subgroup Analysis of East Asian Patients from the FIGHT trial

^○Kensei Yamaguchi¹, Ooki Akira¹, Kang Yoon-Koo², Lee Keun-Wook³, Bai Li-Yuan⁴, Collins Helen⁵, Yang Yingsi⁵, Mezzi Khalid⁵, Catenacci Daniel⁶, Enzinger Peter⁷, Wainberg Zev⁸ (1.Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 2.University of Seoul, South Korea, 3.Seoul National University Bundang Hospital,South Korea, 4.China Medical University, Taiwan, 5.Amgen Inc, United States, 6.University of Chicago, United States, 7.Dana Farber Cancer Institute, United States, 8.University of California, Los Angeles, United States)